Merck v. USA, the most productive of ASCO, and Leqembi on the FDA

Are drug costs safe via the Charter? Will Medicare embody Alzheimer’s illness remedies? And must attorneys be allowed to make use of thesauruses?

We duvet all that and extra this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to give an explanation for Merck’s lawsuit in opposition to the government and why the corporate believes drug pricing negotiation is “tantamount to extortion.” We additionally speak about the well being results of Canadian wildfires, the highlights of the 12 months’s largest most cancers analysis convention, and what is usually a watershed second within the remedy of Alzheimer’s.

For extra on what we duvet, right here’s the most recent on Merck; right here’s extra from ASCO; right here’s the place you’ll to find episodes of Colour Code; and right here’s the place you’ll subscribe to the First Opinion Podcast.

You should definitely enroll on Apple Podcasts, Spotify, Stitcher, TuneIn, or anyplace you get your podcasts.

And when you’ve got any comments for us — subjects to hide, visitors to ask, vocal tics to stop — you’ll electronic mail [email protected].